Reasons for performing study: Neonatal encephalopathy is the most common neurological abnormality identified in neonatal foals, but its clinical course has been rarely characterised. Objectives: To describe factors associated with nonsurvival in a population of foals diagnosed with neonatal encephalopathy. Study design: Retrospective cross-sectional clinical study. Methods: Cases were selected from equine neonatal (≤14 days of age) admissions between 1996 and 2007. Multivariable logistic regression was used to identify clinical parameters, laboratory variables and therapeutic interventions associated with nonsurvival. Results: A total of 94 foals were included in the study. Median age at admission was 12 h (range 0-96 h). The most frequently identified clinical signs included abnormal udder seeking (59%), abnormal suckle (55%), inability to stand (42%), abnormal gastrointestinal motility (37%), abnormal consciousness (34%) and seizure activity (22%). Overall, 75 (79.8%) foals survived to be discharged from the hospital and 19 foals died or were subjected to euthanasia. Variables significantly associated with nonsurvival in the multivariable model were serum total calcium concentration, serum activity of alkaline phosphatase, recumbency, number of concurrent diseases, and use of vasopressors/inotropes. The model correctly classified 92.0% of cases. Conclusions: Overall survival was good and similar to previous reports. Vasopressors/inotropes were the only therapeutic intervention associated with nonsurvival, suggesting that persistent hypotension is associated with nonsurvival in the current population. Foals with concurrent disease, high total calcium and low alkaline phosphatase at admission, and that were recumbent or required treatment with vasopressors/inotropes during hospitalisation, were significantly less likely to survive.
Introduction
Neonatal encephalopathy (NE) is typically recognised as the most common neurological disorder affecting neonatal foals [1] . The syndrome has many synonyms, including hypoxic ischaemic encephalopathy, perinatal asphyxia syndrome, neonatal maladjustment syndrome and dummy foal syndrome. The nomenclature describes the clinical appearance and proposed aetiologies, which include brain hypoxia and ischaemia, and persistence of the fetal hypothalamic-pituitary-adrenocortical axis [2, 3] . Affected animals are either born showing abnormalities or develop clinical signs of disease within a few days after birth. The most commonly reported clinical signs include alterations of consciousness, inability to suckle, lack of affinity for the mare, tongue protrusion, star-gazing, and localised and generalised seizures, among many others. Diagnosis is typically made by excluding infectious or congenital disorders, and prognosis is generally good in uncomplicated cases [1] .
Despite several anecdotal reports about prognostic factors and effective treatments for NE, scientific evaluation of this information is lacking. Our primary study goal was to evaluate factors associated with nonsurvival in foals diagnosed with NE. A secondary study goal was to characterise the most common clinical and clinicopathological abnormalities in affected foals.
Materials and methods

Inclusion criteria
Cases were selected retrospectively from equine neonatal (≤14 days of age) admissions to the Large Animal Hospital at the University of Florida between January 1996 and June 2007 for which a diagnosis of neonatal encephalopathy or any of its synonyms was made. Foals were excluded if meningitis or congenital neurological abnormalities were suspected or confirmed.
Factors included in analysis
Information recovered from the medical records included the following dichotomous (yes/no) variables: male sex, Thoroughbred breed, survival to hospital discharge, presence of concurrent problems, IgG <4 g/l, IgG <8 g/l, inability to stand, abnormal gastrointestinal motility, abnormal consciousness, cranial nerve dysfunction, oedema, abnormal posture/ muscle tone, abnormal pupils, abnormal respiratory pattern, seizure activity, sporadic myoclonus, abnormal suckle, abnormal udder seeking, antibiotic administration prior to admission, positive blood culture, delivery via caesarean section, corneal ulceration, diarrhoea, delivery deemed a dystocia, onset of clinical signs prior to admission, mare's placenta deemed abnormal, recumbent (unable to stand with assistance at any point), and use of the following: mechanical ventilation, respiratory stimulants (doxapram and caffeine), vasopressors/inotropes, dimethyl sulfoxide (DMSO), mannitol, magnesium sulfate, vitamin E.
Vital signs and laboratory variables were taken at or near the time of admission. Clinical signs and therapeutic interventions covered the duration of hospitalisation. The following were recorded as continuous or discrete variables: age at admission (hours), gestation length (days), temperature (F), duration of hospital stay (days), initial weight (kg), final weight (kg), weight gain (kg), respiratory rate (breaths/min), heart rate (beats/min), sepsis score [4] , number of concurrent problems and litres of plasma administered. In addition the durations (days) of the following were recorded: inability to stand, abnormal gastrointestinal motility, abnormal consciousness, cranial nerve dysfunction, oedema, abnormal posture/ muscle tone, abnormal pupils, abnormal respiratory pattern, seizure activity, sporadic myoclonus, abnormal suckle, abnormal udder seeking, enteral feeding, intranasal oxygen insufflation, parenteral nutrition administration and intravenous fluid administration. Continuous laboratory parameters recorded included the following: total white blood cell count, total red blood cell count, packed red cell volume, mean corpuscular volume, mean corpuscular haemoglobin, mean corpuscular haemoglobin concentration, peripheral myelocyte count, peripheral metamyelocyte count, peripheral band count, peripheral neutrophil count, peripheral lymphocyte count, peripheral monocyte count, plasma protein, fibrinogen, platelet count, sodium, potassium, chloride, magnesium, creatinine, blood urea nitrogen, calcium, phosphorus, bilirubin, alkaline phosphatase, aspartate aminotransferase, c-glutamyl transpeptidase, creatine kinase, arterial pH, arterial partial pressure of carbon dioxide, arterial partial pressure of oxygen, arterial bicarbonate, standard base excess, arterial oxygen saturation and blood lactate.
Data analysis
Data were summarised as median (10th to 90th percentiles) for continuous data and percentages for categorical data. Normality of the data and equality of variances were assessed using Shapiro-Wilk's and Levene's tests, respectively. Comparisons between proportions were done using Fisher's exact test. Because most data were not normally distributed, the Mann-Whitney U test was used to compare continuous variables between survivors and nonsurvivors.
Initial screening of variables potentially associated with nonsurvival was done by univariate logistic regression. Variables with screening P values <0.10 and for which missing data represented <20% of the cases were considered for inclusion in the multivariable model. When correlated variables had variance inflation factors >5.0, only the variable most significantly associated with nonsurvival was included in the model to avoid multicollinearity. When a continuous variable had a nonlinear association with nonsurvival, the variable was dichotomised based on the best cut point as assessed by receiver operating characteristic (ROC) curve analysis. The multivariable model was a backward stepwise model, whereby variables were removed sequentially starting with that having the largest P value until only those variables with P<0.05 remained. Likelihood ratio tests were used to calculate P values for comparison of nested models. Goodness of fit of the final model was evaluated using the Hosmer and Lemeshow test and -2 log likelihood fit statistic. Odds ratios (ORs) and 95% confidence intervals were calculated. An OR greater than one corresponds to a positive association with nonsurvival whereas an OR less than one corresponds to a negative association. The overall ability of the multivariable regression model to predict nonsurvival was assessed by use of ROC curve analysis and the optimal cut point to maximise sensitivity and specificity was reported. For all analyses, P≤0.05 was considered statistically significant.
Results
Ninety-four foals were included in the study. Overall, 75 (79.8%) foals survived to be discharged from the hospital and 19 foals died or were subjected to euthanasia. Of the nonsurvivors, 4 died, 15 were subjected to euthanasia and financial considerations did not appear to play a role in any case.
Comparison of recorded demographic data, clinical signs, therapeutic interventions and laboratory data between survivors and nonsurvivors are presented in Supplementary Items 1-4 , respectively. The most frequently identified clinical signs included abnormal udder seeking (59%), abnormal suckle (55%), inability to stand (42%), abnormal gastrointestinal motility (37%), abnormal consciousness (34%) and seizure activity (22%). Nonsurviving foals were more likely to receive directed therapy with mechanical ventilation, respiratory stimulants and vasopressors/inotropes, but therapy with mannitol, magnesium sulfate, vitamin E, or DMSO did not differ significantly between survivors and nonsurvivors ( Supplementary  Item 3) .
Of the 19 nonsurvivors, necropsy reports were available for 17, and microscopic descriptions of brain sections were available for 11. One of the nonsurvivors died after discharge from the hospital and did not return for necropsy. Eleven nonsurviving foals had severe pneumonia or other forms of disseminated sepsis or sepsis-associated complications such as vascular thrombosis. Ten of 11 foals had histological evidence of neuronal necrosis and/or degeneration within the central nervous system (CNS) consistent with ischaemia; 6 were apparently septic, 4 were not. One foal had a spinal haematoma without accompanying microscopic description of the brain. One foal died of a gastric rupture associated with mesenteric root volvulus.
Of the concurrent diseases other than sepsis, the following were reported most frequently: pneumonia (17 foals), prematurity/dysmaturity (12), patent urachus/omphalitis (11), limb deformity (9), colic (4) and uroperitoneum (3) . Fifteen other disorders were reported in one foal each; 14 foals had a sole diagnosis of neonatal encephalopathy.
Variables potentially associated with nonsurvival by univariate logistic regression are presented in Supplementary Item 5. Variables significantly associated with nonsurvival in the multivariable model were total calcium, alkaline phosphatase, recumbency, number of concurrent diseases, and the need for use of vasopressors/inotropes (Table 1) . Complete data on all 5 variables included in the final model were available for 87 foals, of which 69 survived and 18 died. The model correctly classified 92.0% of the cases. The area under the ROC curve for the ability of the variables in the final model to predict nonsurvival was 0.948 (95% confidence interval, 0.878-0.984; P<0.0001). By use of a cut point of >0.451, the sensitivity of the model was 77.8% and specificity was 98.6%.
Discussion
Although neonatal encephalopathy is frequently encountered by equine clinicians, this is the first detailed report of clinical and clinicopathological findings in such foals along with an analysis of their impact on short-term survival. Overall survival was high (79.8%), similar to other retrospective reports [5, 6] and reviews [1, 7, 8] . Of the 19 nonsurvivors, 15 were subjected to euthanasia, and financial consideration did not appear to be the primary reason for euthanasia in any of the foals. Pneumonia, disseminated sepsis, or any of several sepsis-associated complications was the primary reason for death or euthanasia in 11 of 17 foals for which necropsy results were available. One foal suffered from an intestinal accident. In 5 foals, death appeared related to primary neurological disease or multi-organ failure secondary to ischaemia.
A major limitation of this study is the lack of definitive antemortem tests for the diagnosis of neonatal encephalopathy (NE). As a result, the diagnosis of NE relied strictly on clinical diagnosis. Post mortem examination confirmed the diagnosis in 10 cases in which histopathology of the brain was performed. However, it is possible that altered mentation in some foals classified as having NE in the present study was the result of a systemic illness rather than the result of brain injury. Moving forward, evaluation of neuroactive progestagen concentrations may be helpful in some cases [2, 9] . Another limitation is the retrospective collection of data from the medical records. Thus, it is possible that some subjective criteria, such as diarrhoea or pneumonia, were either under-or over-reported.
None of the demographic or historical variables were retained in the final model with the exception of multiple diagnoses. Foals with multiple comorbidities were less likely to survive. While this is not a surprising finding, it is infrequently evaluated in reports of factors associated with 2% ) appeared strongly associated with nonsurvival in the current population. Median gestational length was shorter in nonsurvivors, and the 10th percentile extended well below the typically accepted upper limit of prematurity (320 days) for nonsurvivors (306 days) but not survivors (322 days). Of the 12 foals diagnosed with prematurity/ dysmaturity, 6 survived and 11 had at least one other comorbidity. Thus, while gestational length was not specifically retained in the final model, the effect of prematurity on survival was probably multifactorial and evident in the negative impact of multiple diagnoses upon survival in the current population. Clinical signs were similar to those previously described, with abnormal udder seeking and abnormal suckling most commonly reported [1, 7] . Of the clinical signs, only recumbency was significantly associated with nonsurvival in the final multivariable analysis.
A previous retrospective study of 78 foals with NE described high serum creatinine concentration (32%) and high serum creatine kinase activity (61%) as the most common clinicopathological abnormalities [5] . Although both abnormalities were common in the current population, neither had a significant impact on nonsurvival. The only clinicopathological values retained in the final model were total calcium concentration and serum alkaline phosphatase activity. The positive association between calcium concentration and nonsurvival is interesting, given that many (if not most) of the nonsurvivors had multiple comorbidities, including sepsis. Hypocalcaemia has been reported in septic foals [10, 11] . Septic foals also reportedly have higher serum parathyroid hormone (PTH) and phosphorus concentrations [11] and lower serum 25-hydroxyvitamin D 3 (25(OH)D 3 ) and 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) relative to healthy and sick, nonseptic foals [10] . In one of those reports, high PTH concentrations were associated with nonsurvival whereas neither total nor ionised calcium concentration had a significant association [11] . In the other, low serum 25 (OH)D 3 was associated with nonsurvival in hospitalised foals whereas PTH, total calcium and phosphorus did not have a significant association [10] . Because ionised calcium, 25(OH)D 3 , 1,25(OH) 2 D 3 and vitamin D binding protein were not recorded and/or measured, a complete picture of calcium homeostasis in the current population is not available.
Many therapies have been recommended anecdotally for foals diagnosed with neonatal encephalopathy [1] . In this study population, the only therapy retained in the final model was the use of vasopressors/inotropes. The odds of nonsurvival in foals administered vasopressors was 19 times higher than that of foals that did not receive vasopressors. It is most likely that vasopressor or inotrope therapy is a proxy for hypotension associated with shock or multi-organ system dysfunction. Because the study population covered a wide range of years and supervising clinicians, a wide variety of therapeutic interventions were evaluated, none of which retained a significant impact on nonsurvival in the final model. This finding supports the clinical impression that supportive nursing care is the therapy most essential to a positive outcome in affected foals [1, 8] .
The study population consisted solely of foals referred for intensive care. Thus, selection bias probably favoured severely affected foals and the prognosis for survival in an ambulatory population may be higher than that reported. Thus, some factors associated with nonsurvival, such as the use of vasopressors/inotropes, may not be directly applicable to foals treated in an ambulatory setting. Nevertheless, an overall good prognosis can be relayed when discussing the pros of referral for supportive care vs. the obvious con of relatively high cost with owners of foals with neonatal encephalopathy in a field setting. Similarly, the potential impact of recumbency, shock and multiple comorbidities can be factored into treatment and referral decisions, along with discussions of their potential impact upon prognosis.
In conclusion, the overall prognosis in this study population of foals with neonatal encephalopathy was good. Foals with high total calcium or low alkaline phosphatase at admission, or those that became recumbent, required treatment with vasopressors/inotropes or had multiple comorbidities at any point during hospitalisation were significantly less likely to survive.
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